Genital tract bacterial infections could induce abortion and are some of the most common complications of pregnancy; however, the mechanisms remain unclear. We investigated the role of prostaglandins (PGs) in the mechanism of bacterial lipopolysaccharide (LPS)-induced pregnancy loss in a mouse model, and we hypothesized that PGs might play a central role in this action. LPS increased PG production in the uterus and decidua from early pregnant mice and stimulated cyclooxygenase (COX)-II mRNA and protein expression in the decidua but not in the uterus. We also observed that COX inhibitors prevented embryonic resorption (ER). To study the possible interaction between nitric oxide (NO) and PGs, we administered aminoguanidine, an inducible NO synthase inhibitor. NO inhibited basal PGE and PGF 2␣ production in the decidua but activated their uterine synthesis and COX-II mRNA expression under septic conditions. A NO donor (S-nitroso-N-acetylpenicillamine) produced 100% ER and increased PG levels in the uterus and decidua. LPS-stimulated protein nitration was higher in the uterus than in the decidua. Quercetin, a peroxynitrite scavenger, did not reverse LPS-induced ER. Our results suggest that in a model of septic abortion characterized by increased PG levels, NO might nitrate and thus inhibit COX catalytic activity. ER prevention by COX inhibitors adds a possible clinical application to early pregnancy complications due to infections. embryonic resorption ͉ uteri ͉ decidua ͉ peroxynitrite ͉ sepsis M aternal infections could cause abortion in humans (1, 2), but their mechanism is not clear. Spontaneous and cytokineboosted abortion rates have been linked to exposure to lipopolysaccharide (LPS) in the environment (3). Bacteria could enter the uterus with ejaculate or by intestinal absorption (4). Previously, we developed a mouse model to study LPS-induced pregnancy loss (5). LPS (1 g/g i.p.) injected on day 7 of pregnancy produced 100% embryonic resorption (ER) at 24 h, with fetal expulsion at 48 h. Nitric oxide (NO) produced by inducible NO synthase (iNOS) plays a key role in ER (5). LPS produced systemic effects but did not affect the mothers' survival or future pregnancies.
M
aternal infections could cause abortion in humans (1, 2) , but their mechanism is not clear. Spontaneous and cytokineboosted abortion rates have been linked to exposure to lipopolysaccharide (LPS) in the environment (3) . Bacteria could enter the uterus with ejaculate or by intestinal absorption (4) . Previously, we developed a mouse model to study LPS-induced pregnancy loss (5) . LPS (1 g/g i.p.) injected on day 7 of pregnancy produced 100% embryonic resorption (ER) at 24 h, with fetal expulsion at 48 h. Nitric oxide (NO) produced by inducible NO synthase (iNOS) plays a key role in ER (5) . LPS produced systemic effects but did not affect the mothers' survival or future pregnancies.
Prostaglandin (PG) biosynthesis is catalyzed by cyclooxygenase (COX) I and II, the later being inducible by proinflammatory agents such as cytokines and LPS (6) (7) (8) . It is well known that PGs mediate septicemic signs and symptoms of Gram-negative bacterial infections and stimulate contractility of the myometrium (9, 10) . Thus, PGs are considered to be effective abortifacients and are important mediators of LPS-induced ER and preterm labor. Silver et al. (11) showed that deciduae from LPS-treated mice produce inflammatory eicosanoids as PGE 2 , PGF 2␣ , and thromboxane B 2 and that indomethacin (Indo), a nonselective COX inhibitor, prevents abortion.
A significant body of experimental evidence suggests a relationship between NO and PGs (12, 13) , particularly in pathophysiologic events associated with gestation. In our laboratory we found that epidermal growth factor and IL-1␣ enhance PG production by stimulating iNOS activity (14, 15) and that Indo stimulates NO during the implantation period in the rat (16) . The aim of this study was to characterize PGE and PGF 2␣ generation in the LPS-induced ER model and to determine whether NO and PGs interact in this model.
Results

Participation of PGs in LPS-Induced ER. Effect of COX inhibitors.
We have previously observed (5) that relatively low doses of LPS on day 7 of pregnancy produced 100% ER. The resorption process finishes when the remaining implantation sites are totally expelled by the mother without evidence of gestation a few days later.
Here we found that coinjection of LPS and Indo, a nonselective COX inhibitor, partially blocked LPS-induced ER (Table 1) . Furthermore, Melo and Cele, two selective COX-II inhibitors, diminished to a higher extent the abortogenic phenotype. Animals treated with LPS ϩ COX inhibitors did not show signs of fetal expulsion, and all of the females delivered live litters. COX inhibitors produced lower birth weight pups with normalization during lactation (data not shown). These results suggest that PGs might be involved in LPS-induced ER and that COX-II could be the implicated isoform. PG synthesis. PGE and PGF 2␣ production was detectable in both the decidua and uterus in control animals after 6 h of PBS administration. LPS increased PG production in the uterus and decidua (Fig. 1) , and Indo decreased basal and LPS-stimulated PG levels in both tissues. Melo, a COX-II selective inhibitor, partially reversed PG increases in the uterus (Fig. 1 A) and PGF 2␣ synthesis in the decidua (Fig. 1B) , where it completely abolished the PGE increase due to LPS. These results reinforce the idea that COX-II might be responsible for the augmented synthesis of PGs due to LPS.
In vitro treatment with another COX-II inhibitor, NS-398 (30 ng/ml), completely reversed PGE (uterus: LPS 459.5 Ϯ 18.2 vs. LPS ϩ NS-398 336.4 Ϯ 33.1 pg/mg wet weight (ww), P Ͻ 0.05; decidua: LPS 950.6 Ϯ 96 vs. LPS ϩ NS-398 335.6 Ϯ 37.2 pg/mg ww, P Ͻ 0.001) and PGF 2␣ increases (uterus: LPS 1,034 Ϯ 72 vs. LPS ϩ NS-398 818.4 Ϯ 35.8 pg/mg ww, P Ͻ 0.05; decidua: LPS 541.3 Ϯ 20.4 vs. LPS ϩ NS-398 407.3 Ϯ 16.7 pg/mg ww, P Ͻ 0.05), suggesting that COX-II may increase PG synthesis due to LPS.
Although the dose of LPS administered was quite low, it produced visible systemic inflammatory effects such as diarrhea, piloerection, and bent posture (5) . LPS-induced PG synthesis was only observed at the implantation sites. Other tissues such as adrenal glands did not show any change in PG content (PGF 2␣ : control 577.4 Ϯ 47 vs. LPS 659.7 Ϯ 61.3 pg/mg ww; PGE: control 676.9 Ϯ 40.5 vs. LPS 770.9 Ϯ 56.43 pg/mg ww). COX mRNA. We investigated whether LPS could modulate the COX synthesis pathway. COX-I mRNA did not change in the uterus or decidua. In contrast, 2 h after LPS treatment, uterine COX-II mRNA was increased 4-fold compared with the control group ( Fig. 2A) . After 6 h, COX-II mRNA expression was strongly stimulated. However, in the decidua only a slight augmentation was observed (Fig. 2B) . COX protein levels. COX-I was undetectable by Western blot analysis in the uterus and decidua at any time and under any treatment (data not shown). We found a tissue and temporal regulation pattern for COX-II protein expression. Uterine COX-II protein levels decreased 3 h after LPS administration and remained low at 6 h (Fig.  3A) . In the decidua, LPS increased COX-II protein levels by 2-, 4-, and 7-fold at 2, 3, and 6 h, respectively (Fig. 3B) . Immunolocalization of COX isoforms. Localization of COX protein among treatment groups was examined by immunohistochemistry on day-7 implantation site sections. Tissues were removed 6 h after LPS administration when maximal NO synthesis was detected (5). Immunoreactive COX-I (sections not shown) and COX-II were present in implantation sites in all groups analyzed. Both isoforms were localized only in the decidual tissue and were not detected in the nonmodified endometrium, myometrium, or vascular smooth muscle (Fig. 4) . Glandular epithelium showed low COX staining in only a few glands.
The subcellular distribution patterns of COX-I and COX-II proteins were localized exclusively in the cytoplasm of decidual cells. Many decidual cells showed perinuclear labeling. These findings are in accordance with the well known subcellular localization of COX in the luminal surfaces of the endoplasmic reticulum and nuclear envelope. Some cells showed granular staining, whereas others presented a diffuse gold color throughout the cytoplasm.
Interaction Between COX and NOS Pathways. Effect of NO on COX pathway. It was reported that eicosanoid production may interact with the NO biosynthetic pathway (17) (18) (19) . We have found that LPS produced a significant NO increase at implantation sites (5), and it is well known that PGs augment during implantation (20) and sepsis (21, 22) . Thus, we investigated the possible crosstalk between NO and PG pathways in our model. Aminoguanidine (AG), a selective iNOS inhibitor, reversed LPS-induced ER by 52% (5). Here we found that AG increased basal PGE synthesis and abolished LPS-induced PG production in the uterus (Fig. 5A ). In the decidua, AG increased basal PGF 2␣ production and did not alter PG levels in LPS ϩ AG-treated animals (Fig. 5B) . Thus, NO could have a dual role in PG synthesis. In a physiological context such as normal pregnancy, NO might inhibit PG synthesis, thus contributing to uterine quiescence. In a pathological event such as septic abortion, NO might participate in the mechanism of the LPS-induced PG increase.
Then, we examined the effect of S-nitroso-N-acetylpenicillamine 
Day-7 pregnant mice were injected with PBS (control), LPS (1 g/g), LPS ϩ Indo (2.5 mg/kg), LPS ϩ Melo (4 mg/kg), LPS ϩ Cele (3 mg/kg), LPS ϩ quercetin (10 mg/kg), or SNAP alone (3 mg/kg) and were killed on day 12; % ER was calculated as mentioned before. Values are means Ϯ SEM. * , P Ͻ 0.001 vs. control group; †, P Ͻ 0.01 vs. LPS-treated group. (SNAP), a NO donor. SNAP administration to day-7 pregnant mice elicited 100% ER as previously observed for LPS (Table 1 ). In the uterus, SNAP increased PGE and PGF 2␣ just 1 h after its administration, and they remained high until 4 and 2 h, respectively, after the SNAP treatment (Fig. 6A ). In decidua, SNAP increased PGF 2␣ at 2 h and PGE production 1, 2, and 4 h after its administration (Fig.  6B) . These results suggest a critical role for NO in PG augmentation and the progression of ER. AG decreased COX-I and COX-II mRNA levels in decidua and uterus, respectively (Fig. 7) , suggesting that basal iNOS-derived NO might positively regulate COX mRNA expression. AG partially abrogated uterine LPS-induced COX-II mRNA, suggesting that NO could be participating in the effect of LPS on PG synthesis. Also, strong COX-II immunostaining was observed in AG-treated animals (Fig. 4) . This suggests that NO or its metabolites could inhibit COX-II expression in LPS-treated animals.
Effect of PGs on NO pathway. COX products could modulate NOS activity (23, 24) . Thus, we investigated NOS activity in the presence of selective COX inhibitors 6 h after treatment, when maximum NO production occurs because of LPS administration (5). Melo administration inhibited the LPS effect on uterine NOS activity (Fig. 8A) , whereas Cele diminished it in the decidua (Fig. 8B) . Participation of NO-derived reactive species. Several forms of NOderived reactive species could be synthesized in different biological systems. The administration of quercetin, a peroxynitrite scavenger (25) , with LPS did not prevent LPS-induced ER (Table 1) , indicating that peroxynitrite is not involved in the ER process.
Tyrosine nitration is becoming increasingly recognized as a functionally significant posttranslational protein modification that serves as an indicator of NO-mediated oxidative inflammatory reactions (26) (27) (28) . We detected nitration of COX-II tyrosine residues (29, 30) at each time analyzed and in control mice injected with PBS. After LPS administration, uterine nitrated levels were higher than nonmodified COX-II expression (Fig. 9 ). This result suggests that LPS might induce a rapid nitration of uterine COX-II protein, which reached a maximum 3 h later. In contrast, decidual COX-II protein levels were significantly higher than nitrate COX-II expression after LPS treatment, which did not differ from control (Fig. 9) . 
Discussion
Genitourinary tract or systemic infections with Gram-negative bacteria in pregnant women could cause abortion and several other perinatal complications. LPS is the most potent antigenic component of the Gram-negative bacterial cell wall and is known to modulate the expression of various proinflammatory cytokines (31) . Also, it is a well-known inducer of abortion in mice as implantation sites are very sensitive to inflammation (32, 33) . Relatively low doses of LPS do not endanger the survival of the mother but produce complete ER after local activation of NO production (33, 34) . NO is a key signaling molecule implicated in central physiological functions (35, 36) but has toxic effects at high concentrations such as those produced in sepsis (37, 38) . Some of these effects are due to peroxynitrites, which could initiate toxic reactions by introducing tyrosine nitration (39) . Previously, we found that LPS-induced pregnancy loss was strongly associated with NO production in the uterus and decidua, as AG partially inhibited ER (5).
During inflammation, PGs are released in large amounts simultaneously with NO, and their overproduction could be detrimental. PGs promote uterine contractions, possibly contributing to embryonic expulsion (40, 41) . Thus, the aim of this study was to characterize PG/COX pathway modulation in a mouse model of septic pregnancy loss.
We observed that COX-II-derived PG synthesis was stimulated under septic conditions in the uterus and decidua. Although COX-II mRNA expression and PG synthesis were stimulated in the uterus, COX-II protein was not increased after LPS treatment as would be expected. One possible explanation is that under septic conditions, NO-derived species could specifically modulate COX expression.
Recent results showed that NO could interfere not only with COX activity but also with COX expression. We hypothesized that NO could be regulating the COX pathway. The literature is divided with respect to whether NO activates or inhibits PG production. Here we observed that NO exerted a tissue-dependent modulation on PG production and elicited different effects, depending on whether basal or LPS-induced conditions were assessed. Thus, we decide to study the possible interaction between PG and oxidant NO-derived molecules in the ER model.
The chemistry of NO at any given moment is the key feature that determines its biological action (42, 43) . NO could react with the superoxide radical and generate peroxynitrite, a key oxidant and nitrating molecule. Indeed, we identified a nitrated band that coincided with COX-II molecular weight in control and LPS- treated implantation sites and whose expression depended on the time and tissue analyzed. This result is in accordance with the reported ''peroxide tone'' (44) necessary for COX activation. Beharka et al. (45) provided strong evidence indicating that peroxynitrite increases COX activity (45) . Our results show that LPS and SNAP increased PG synthesis and the COX-II mRNA level. These could be interpreted as an initial activation after arachidonic acid release, because uterine COX-II expression was decreased whereas nitrotyrosine-COX-II was augmented. Once the synthesizing cascade is initiated, peroxynitrite might nitrate an essential tyrosine residue in COX-II protein, making it incapable of catalysis. COX-II strong immunostaining in the AG-treated group supports this supposition. These results suggest that the NO inhibitory effect might involve nitration of COX tyrosine residues, whereas the stimulatory effect is likely to be the result of peroxynitrite functioning as a peroxide activator of PG signaling. There is some evidence that LPS treatment decreases activity of prostaglandin 15-hydroxydehydrogenase (46) , the enzyme responsible for the first step in PG degradation, in term fetal membranes (47) and that LPS alters PG 15-dehydrogenase mRNA and protein levels in mouse lung after stress (48) . Therefore, LPS-induced PG levels may be due to not only increased PG synthesis but also decreased PG 15-dehydrogenase activity/expression and hence PG degradation. A possible effect of LPS on PG degradation could not be ruled out in this model. Finally, although SNAP, a NO donor, produced ER, quercetin, a flavonoid with antioxidant activity including scavenging of radicals and inhibition of lipid peroxidation, did not reverse ER, suggesting that NO per se could be an effective inducer of abortion and nitration but might not be the prevalent mechanism underlying septic pregnancy loss.
All together our work shows the relevant role that PGs might have in LPS-induced ER and the dual effect of NO on their synthesis. Importantly, the fact that COX inhibitors partially prevented septic abortion suggests that they could be used in the future as therapeutic agents in this pathological condition.
Materials and Methods
Drugs and Chemicals. L-[ 14 C(U)]Arginine (specific activity 360 mCi/mmol) and [5, 6, 8, 11, 12, 14, H(N)]-PGE 2 (specific activity 150 Ci/mmol) were purchased from PerkinElmer Life and Analytical Sciences; [5, 6, 8, 9, 11, 12, 14, H(N)]PGF ␣2 (specific activity 200 Ci/mmol) was purchased from GE Healthcare Biosciences; Melo was purchased from Boehringer Ingelheim and Cele was purchased from Panalab S.A. Argentina. LPS of Escherichia coli 05:B55, Indo, AG, PGE, and PGF 2␣ standards and secondary antibodies were from Sigma Chemical. The Dowex AG50-X8 column (Na ϩ form), nitrocellulose membranes, and all other Western blot reagents were from Bio-Rad. NS-398 and primary COX antibodies for Western blots were from Cayman Chemical. Polyclonal COX-I and COX-II antibodies for immunohistochemistry were from Santa Cruz Biotechnology. The CSA/HRP kit and preimmune sera were purchased from Dako. All other chemicals were analytical grade.
Animals and Treatments. BALB/c female mice from 8 to 12 weeks old were paired with adult BALB/c male mice. Day 0 of gestation was determined when the vaginal plug was observed. Animals received food and water ad libitum and were housed under controlled conditions of light (12-h light, 12-h dark) and temperature (23Ϫ25°C). Females were killed by cervical dislocation. The experimental procedures reported here were approved by the Animal Care Committee of the Centro de Estudios Farmacologicos y Botanicus-Consejo Nacional de Investigaciones Científicas y Téc-nicas de Argentina and carried out in accordance with the internationally accepted principles for the use of experimental animals.
The uterus and decidua from each implantation site were separated and immediately frozen at Ϫ70°C. For RT-PCR assays, tissues were immediately homogenized in TRIzol and frozen at Ϫ20°C. In vitro assays were performed using NS-398 (30 ng/ml). Control and LPS groups of mice were injected i.p. with PBS or LPS (1 g/g), respectively, on day 7 of pregnancy. Cele (3 mg/kg) and Melo (4 mg/kg) were injected together with LPS and alone 4 h later. AG (6 mg per mouse) and LPS ϩ AG groups received three doses of AG: the first dose on day 6, the second together with PBS or LPS on day 7, and the third dose 4 h later. Groups of animals injected with Indo (2.5 mg/kg), SNAP (3 mg/kg), or quercetin (10 mg/kg) received only one dose of the drug on day 7. To determine the percentage of ER, animals were injected on day 7 of pregnancy and killed on day 12.
Determination of NOS Activity. Animals were killed 6 h after LPS injection. NOS enzyme activity was quantified by the modified method of Bredt and Snyder (49) COX Immunohistochemistry. Animals were killed 6 h after LPS injection. Western Blot Analysis. Animals were killed 2, 3, and 6 h after LPS injection. Samples for COX detection were homogenized in radioimmunoprecipitation assay modified buffer (50 mM Tris⅐HCl, pH 7.4, containing 1% Triton X-100, 150 mM NaCl, 1 mM EDTA, 0.25% sodium deoxycholate, 2 g/ml aprotinin, 10 g/ml leupeptin, 10 g/ml DTT, 100 g/ml soybean trypsin inhibitor, 1 mg/ml caproic acid, and 1 mg/ml benzamidine). Homogenates were sonicated for 30 s and centrifuged at 1,500 ϫ g for 5 min. Protein concentration was determined by the Bradford assay (51). Total protein (1 mg) was immunoprecipitated with concentrated COX antibody overnight at 4°C. Samples were incubated with ASepharose protein and centrifuged at 15,700 ϫ g for 1 min. Finally, samples were boiled in sample buffer. Positive controls were mouse macrophage lysate for COX-II and rat seminal vesicle for COX-I. Nitrotyrosine-COX samples were homogenized in PBS buffer with inhibitors. All samples were run in a 4% 0.125 M Tris (pH 6.8) stacking polyacrylamide gel, followed by a 10% 0.375 M Tris (pH 8.8) separating polyacrylamide gel. Proteins were transferred overnight at 4°C. Membranes were blocked in PBS containing 5% milk powder and incubated overnight at 4°C with the murine COX-II polyclonal antibody (1:500). Then they were stripped and incubated with rabbit anti-nitrotyrosine immunoaffinity-purified IgG (1:200). The second antibody (anti-rabbit Ig peroxidase, 1:5,000, containing 5% milk powder) was incubated for 1 h at room temperature. Proteins were detected using HRP-conjugated secondary antibody or chemiluminescence. Blots were recorded with a digital camera, and the intensity of bands was determined using the Image J (National Institutes of Health, Bethesda, MD) program. ␤-Actin was used as the loading control.
PG RIA. PG levels were determined as in ref. 52 . Values were expressed as picograms of PG synthesized per milligram of wet weight per hour.
ER Rate. Resorption rates were calculated as (number of dead embryos/number of healthy embryos ϩ number of dead embryos) ϫ 100. Animals were tested for term labor, and pups were weighed until 1 month of age.
Statistics. Statistical analyses were performed using the Instat Program (Graph Pad Software). Comparisons between values were performed using Student-Newman-Keuls multiple comparison tests and one-way ANOVA (ANOVA and significances were determined using Tukey's multiple comparison test) for unequal replicates. Differences between means were considered significant at P Յ 0.05. Percent ER was analyzed using a 2 test.
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